MAITREYA

Maitreya Medicare Share Price

 

 

Start SIP in MAITREYA

Start SIP

Performance

  • Low
  • ₹255
  • High
  • ₹287
  • 52 Week Low
  • ₹214
  • 52 Week High
  • ₹362
  • Open Price₹282
  • Previous Close₹287
  • Volume27,200

Investment Returns

  • Over 1 Month + 1.24%
  • Over 3 Month -2.14%
  • Over 6 Month -7.61%
  • Over 1 Year -21.97%

Smart Investing Starts Here Start SIP with Maitreya Medicare for Steady Growth!

Invest Now

Maitreya Medicare Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 94.3
  • PEG Ratio
  • -
  • Market Cap Cr
  • 177
  • P/B Ratio
  • 6.7
  • Average True Range
  • 16.56
  • EPS
  • 2.74
  • Dividend Yield
  • 0
  • MACD Signal
  • 1.49
  • RSI
  • 53.97
  • MFI
  • 66.7

Maitreya Medicare Financials

Maitreya Medicare Technicals

EMA & SMA

Current Price
₹260.55
-26 (-9.07%)
pointer
  • Bearish Moving Average 5
  • Bullish Moving Average 11
  • 20 Day
  • ₹252.76
  • 50 Day
  • ₹250.89
  • 100 Day
  • ₹257.10
  • 200 Day
  • ₹263.85

Resistance and Support

267.37 Pivot Speed
  • R3 311.13
  • R2 298.82
  • R1 279.68
  • S1 248.23
  • S2 235.92
  • S3 216.78

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Maitreya Medicare Ltd has an operating revenue of Rs. 70.71 Cr. on a trailing 12-month basis. An annual revenue de-growth of -2% needs improvement, Pre-tax margin of 7% is okay, ROE of 7% is fair but needs improvement. The company has a reasonable debt to equity of 14%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 15% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 9 which is a POOR score indicating inconsistency in earnings, a RS Rating of 54 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 40 indicates it belongs to a strong industry group of Medical-Hospitals and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Maitreya Medicare Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-14 Quarterly Results
2025-05-30 Audited Results
2024-10-28 Quarterly Results
2024-05-28 Audited Results
2024-02-13 Quarterly Results

Maitreya Medicare F&O

Maitreya Medicare Shareholding Pattern

73%
0%
21%
6%

About Maitreya Medicare

  • NSE Symbol
  • MAITREYA
  • BSE Symbol
  • Chairman & Managing Director
  • Dr. Narendra Singh Tanwar
  • ISIN
  • INE0PLQ01011

Similar Stocks to Maitreya Medicare

Maitreya Medicare FAQs

Maitreya Medicare share price is ₹260 As on 17 November, 2025 | 17:52

The Market Cap of Maitreya Medicare is ₹176.5 Cr As on 17 November, 2025 | 17:52

The P/E ratio of Maitreya Medicare is 94.3 As on 17 November, 2025 | 17:52

The PB ratio of Maitreya Medicare is 6.7 As on 17 November, 2025 | 17:52

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23